UPDATE April 2013 Biogen’s BG-12 has been approved by the FDA and is now marketed under the name Tecfidera. Google News reported 28 Feb 2012 that Biogen Idec has submitted for FDA approval for new drug to treat Multiple Sclerosis. The drug is known as BG-12 (Dimethyl Fuerate). Multiple Sclerosis impacts more that 400, 000… Continue reading Nrf2 Drug Submitted for FDA approval for Multiple Sclerosis (MS)